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Abstract 
Background: The 2016 guidelines of the American Society of Echocardiography (ASE) and European Association of 
Cardiovascular Imaging (EACVI) for evaluation of left ventricular (LV) diastolic dysfunction by Doppler flow and tissue 
Doppler- echocardiography do not adjust assessment of high filling pressures for patients with aortic stenosis (AS). 
However, most of the studies on this patient group indicate age independent specific diastolic features in AS. The aim 
of this study is to identify disease-specific range and distribution of diastolic functional parameters and their ability 
to identify high N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels as a marker for high filling 
pressures.
Methods: In this study, 169 patients who underwent surgical aortic valve replacement (SAVR) or transcatheter aortic 
valve replacement (TAVR) were prospectively enrolled. Resting echocardiography was performed including Dop-
pler of the mitral inflow, pulmonary venous flow, tricuspid regurgitant flow and tissue Doppler in the mitral ring and 
indexed volume-estimates of the left atrium (LAVI). Echocardiography, and NT-proBNP levels were assessed before 
TAVR/SAVR and at two postoperative visits at 6 and 12 months.
Results: Pre- and postoperative values were septal e′; 5.1 ± 3.9, 5.2 ± 1.6 cm/s; lateral e′ 6.3 ± 2.1; 7.7 ± 2.7 cm/s; 
E/e′19 ± 8; 16 ± 7 cm/s; E velocity 96 ± 32; 95 ± 32 cm/s; LAVI 39 ± 8; 36 ± 8 ml/m2, pulmonary artery pressure (PAP) 
39 ± 8; 36 ± 8 mmHg, respectively. The scoring recommended by ASE/EACVI detected elevated NT pro-BNP with a 
specificity of 25%. Adjusting thresholds towards PAP ≥ 40 mmHg, E velocity ≥ 100 cm/s, E deceleration time < 220 ms, 
and E/septal e′ ≥ 20 or septal e′ < 5.0 cm/s increased prediction of NT-proBNP levels ≥500 ng/L with substantially 
improved specificity (> 85%).
Conclusion: Diastolic echocardiographic parameters in AS indicate persistent impaired relaxation and NT-proBNP 
indicate elevated filling pressures in most of the patients, improving only modestly 6–12 months after TAVR and 
SAVR. Applying the 2016 ASE/EACVI recommendations for detection of elevated filling pressures to patients with AS, 
elevated NT pro-BNP levels could not be reliably detected. However, adjusting thresholds of the echocardiographic 
parameters increased specificities to useful diagnostic levels.
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Introduction
Degenerative aortic valve stenosis (AS) is a chronic and 
progressive disease which gradually provokes afterload 
and thereby causes pressure overload on the left ventri-
cle (LV), leading to ventricular fibrosis and consequently 
diastolic dysfunction over time [1–3]. The associated 
diastolic properties start with delayed relaxation at nor-
mal filling pressures, consecutively facilitating a state 
with increased filling pressures, and finally inducing the 
clinical image of heart failure with pulmonary congestion 
[4].
According to the 2016 recommendations of the Ameri-
can Society of Echocardiography (ASE) and the European 
Association of Cardiovascular Imaging (EACVI), ele-
vated LV filling pressures should be assessed by left atrial 
volume index (LAVI) and blood-flow and tissue Doppler 
parameters, i.e. septal and/or lateral e′ average, E′\e′ ratio, 
peak gradient over the tricuspid regurgitation  (TRpeak) 
[4]. The ASE/EACVI recommend modified assessment-
criteria for hearts with reduced EF and for hearts with 
special forms of cardiomyopathies.
However, in AS, they do not recommend modifica-
tion of these criteria [4], even though altered relaxation 
and filling properties in AS are well known [5–10]. The 
elderly population with AS have a complex structure of 
ventricular diastolic properties with delayed relaxation 
related to age, hypertension and hypertrophy. Using 
unmodified criteria for AS might probably lead to over- 
or under-estimation of filling pressures. Consequently, 
the assessment of diastolic dysfunction in this population 
remains challenging [5–10].
During progression of diastolic dysfunction, LV wall 
stress, pressure and volume overload induce the secretion 
of BNP/ NT-proBNP (N-terminal prohormone of brain 
natriuretic peptide), a cardiac neurohormone which is 
secreted by cardiomyocytes in the ventricles. Several 
studies have shown that high plasma BNP/NT-proBNP 
levels correlate well with elevated filling pressures and 
severity of heart failure in patients with AS [11–13]. An 
age dependent increase of plasma BNP/NT-proBNP lev-
els is observed in population-based studies, while recent 
studies indicate the association with LV hypertrophy or 
subclinical heart failure rather than age only [14, 15].
In this study, we aim to describe diastolic functional 
parameters in elderly patients with severe AS, at baseline 
and after aortic valve replacement (AVR). We also tested 
these parameters and their cut-off values to predict high 




In a prospective study between 2010 and 2013, 169 
patients with severe symptomatic AS, who were eligible 
either for transcatheter AVR (TAVR) or surgical AVR 
(SAVR) at the University Hospital of North Norway 
Tromsø, were consecutively included in the study. The 
decision for TAVR or SAVR was made by a multidiscipli-
nary cardiology team who determined the operation type 
(TAVR or SAVR) based on patients’ indications, technical 
feasibility, the risk for open heart-surgery, age, comorbid-
ities and mental status. Patients who were unable to give 
informed consent, or with life expectancy of less than 
12 months, or with low motivation for interventional 
treatment, were not offered aortic valve replacement of 
any kind. All 169 included participants in the study were 
invited to a pre-operative clinical assessment and echo-
cardiography and NT-proBNP measurement and two 
repeated control investigations at 6 (± 1 month) and 12 
(± 1 month) months after the operation.
Patient demographics and clinical characteristics
Clinical characteristics, mortality and complications dur-
ing and after surgery were obtained from the patients’ 
electronic journals. Patients were classified according to 
the global initiative for chronic obstructive lung disease 
(GOLD) classification for chronic obstructive pulmo-
nary disease (COPD), and the patients with COPD of 
unknown grade were classified as having COPD grade 
1. The patients who had a history of stroke or transient 
ischemic attacks, or significant (> 70%) stenosis of the 
carotid arteries, were classified as having cerebrovascular 
disease. Chronic and paroxysmal atrial fibrillation/flut-
ter conditions were grouped as one variable. The patients 
with records, less than 2 weeks prior to surgery, of physi-
cian documented clinical signs of heart failure in the form 
of unusual dyspnoea on light exertion, orthopnoea, fluid 
retention, description of rales on auscultation, or pulmo-
nary oedema on chest X-ray, were classified as having 
heart failure (HF < 2 weeks). The patients were classified 
as having left bundle branch block (LBBB) according to 
the Minnesota criteria in the resting ECG. Predominance 
Trial registration: The study was prospectively approved by the regional ethical committee, REK North with the 
registration number: REK 2010/ 397- 10.
Keywords: Left ventricular filling pressures, Aortic stenosis, Aortic valve replacement, Doppler echocardiography, 
Brain natriuretic peptide
Page 3 of 14Caglayan et al. Cardiovasc Ultrasound           (2021) 19:32  
of ventricular pacing or LBBB was assessed by the rhythm 
registered during echocardiography.
Echocardiography
All patients underwent preoperative echocardiography 
in the left lateral decubital position with an iE33 scan-
ner (S5–1 probe, Philips Medical systems, Andover, MA). 
Conventional 2-dimensional grey scale images were 
obtained in parasternal long- and short- axes as well as 
apical four-chamber, two-chamber and long-axis-views. 
2D long-axis images were obtained at a time-resolution 
of was 58 ± 20 frames/s. LV EF was derived from the two- 
and four-chamber views using the biplane Simpson’s 
method [16]. The same two views were used to calculate 
LAVI at end-systole. The degree of AS was expressed 
using the mean gradient of the Doppler flow across the 
aortic valve and the indexed aortic valve area calculated 
using the continuity equation.
For the evaluation of mitral regurgitation and aortic 
regurgitation, we performed a multiparametric, semi-
quantitative approach as recommended in the guidelines 
[17].
Diastolic LV function was assessed by evaluation of the 
following parameters: Mitral E- and A-wave velocity, E/A 
ratio, E deceleration time (DT), septal, lateral wall and 
average tissue Doppler velocities (e′) and their E/e′ ratios, 
systolic filling fraction of the pulmonary veins (SFF), 
LAVI, the velocity and peak gradient over the tricuspid 
regurgitation  (TRpeak) and an estimate of the systolic pul-
monary arterial pressure (PAP) by adding 10 mmHg to 
the  TRpeak, and the isovolumetric relaxation time (IVRT).
We applied the scoring system according to the ASE/
EACVI 2016 guidelines based on at least two of the cri-
teria for ventricles with normal EF: septal e′ ≤7 cm/sec 
and/or lateral e′ ≤ 10 cm/sec, average E/e′ ratio ≥ 14 cm/
sec,  TRpeak ≥ 2,8 m/sec and LAVI ≥34 ml/m2. We scored 
also relaxation properties based on the ASE/EACVI 2009 
guidelines, which states the presence of impaired relaxa-
tion if septal e′ < 8; lateral e′ < 10 cm/s or LA ≥ 34 ml/m2.
Finally a new scoring system was established based 
on independent predictors of the multivariate-analysis, 
adding for each variable “− 1” for normal values, “0” for 
intermediate and + 1 for high probability of elevated fill-
ing pressures.
Statistical analysis
Statistical analysis was performed using SPSS 25 and 26 
(SPSS Inc., Chicago, IL, USA). Preoperative patient-char-
acteristics of the TAVR and SAVR groups were compared 
using either t-test or chi-square test. The frequencies of 
categorized diastolic parameters were compared using 
chi-square test to analyse the differences between the age 
groups (≥ or < 80 years) and pre- and postoperative data 
baseline and control after TAVR/SAVR. We compared 
further pre-operative to post-operative echocardio-
graphic diastolic parameters using paired t-test. For this 
comparison, one average value of each parameter was 
calculated for parameters of the first and second post-
AVR control.
Receiver operating characteristic (ROC) curve analy-
sis was performed on pre- and post-operative echocar-
diographic measurements when NT-proBNP values were 
available. The NT-proBNP level > 500 ng/L was chosen 
from the clinical cut-off value in our hospital for the larg-
est age group of patients in our study (females and males 
70–80 years). Age-related cut-off values were not cho-
sen, since the NT-proBNP threshold increased in many 
patients during the first control-year. To identify predic-
tors of elevated NT-proBNP levels, three cut-off values of 
similar sensitivity-specificity-sum were chosen for each 
diastolic parameter, among the values with high sensi-
tivity and moderate specificity and high specificity com-
bined with moderate sensitivity.
For the independent and dependent correlation of 
diastolic echocardiographic indices with the presence of 
NT-proBNP value > 500 ng/L, univariate and multivariate 
logistic regression analysis was performed. Variables with 
p  ≤ 0.05 and deemed clinically relevant were selected 
and tested to analyse interaction and co-linearity prior to 
forward and backward multivariable logistic regression 
analysis. When the interaction terms in the backward 
analysis were non-significant, the forward model was 
used. For the final inclusion into a multiple regression 
model, a p-value of ≤0.05 was considered significant. 
Independent predictors of the multivariable analysis were 
combined in a scoring system. For this new score, sensi-
tivities and specificities were calculated for different cut-
off values using ROC curve analysis.
Results
Over a three-year period, 169 patients were included 
in this study. Twelve patients with a mean gradient 
< 40 mmHg and reduced stroke-volume, indicating a low-
flow low gradient AS, while two patients were referred to 
AVR and CABG presented with a moderate aortic ste-
nosis. One patient referred to TAVR had a gradient of 
38 mmHg and normal stroke volume. At the time of AVR 
referral, all patients presented with exertional dyspnoea 
at least NYHA II, 46% presented with angina, 6% with 
dizziness or syncope and 10% of patients presented with 
additional angina and dizziness.
There was no statistical difference for type of symptoms 
between the TAVI and AVR groups. Eighteen patients 
died during the procedure or during the first 6 months 
after SAVR or TAVR. One hundred thirty-five patients 
returned to either follow-up control, 132 participants 
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attended the first postoperative control at 6 months, and 
121 patients attended the second control at 12 months. 
Of 388 visits of the 169 included patients with NT-
proBNP measurements, NT-proBNP values could be 
linked to echocardiographic parameters in 358 visits.
We compiled baseline demographic and clinical 
characteristics of the patients who underwent TAVR 
and SAVR (Table  1). The TAVR group consisted of 98 
(49% male) patients and the SAVR group of 71 (56% 
male) patients. Patients in the TAVR group were sig-
nificantly older, and had significantly higher body mass 
index (BMI), pulmonary artery pressure (PAP) and NT-
proBNP levels than the patients in the SAVR group. 
More COPD, peripheral vascular disease (PVD) and 
heart failure < 2 weeks cases were observed in the TAVR 
than in the SAVR group. In line with renal dysfunction, 
pre- glomerular filtration rate (GFR) and post-GFR lev-
els were significantly lower in the TAVR group than in 
the SAVR group. The prevalence of previous coronary 
artery bypass grafting (CABG) and percutaneous coro-
nary intervention (PCI), Logarithmic European System 
for Cardiac Operative Risk Evaluation (LogEuroScore) 
and pre-operative functional New York Heart Asso-
ciation (NYHA) class III-IV, were significantly higher 
in the TAVR group, whereas the prevalence of new 
revascularization was significantly higher in the SAVR 
group. There were no statistically significant differences 
in terms of EF, hypertension, diabetes, plasma choles-
terol and creatine kinase-MB (CK-MB) levels, smok-
ing, coronary artery disease (CAD), cerebrovascular 
Table 1 Patient characteristics
BMI Body mass index, CABG Coronary artery bypass grafting, CAD Coronary artery disease, CK Creatine kinase, COPD Chronic obstructive pulmonary disease, EF 
Ejection fraction, GFR Glomerular filtration rate, LBBB Left bundle brunch blocks, LogEuroScore Logarithmic European System for Cardiac Operative Risk Evaluation, 
NT-proBNP N-terminal prohormone of brain natriuretic peptide, NYHA New York Heart Association, PAP Pulmonary artery pressure, PCI Percutaneous coronary 
intention, PVD Peripheral vascular disease, SAVR Surgical aortic valve replacement, TAVR Transcatheter aortic valve replacement
TAVR SAVR P-value
n (%) or mean ± SD n (%) or mean ± SD
n 98 71
Male 48 (49) 40 (56) 0.345
Age (y) 83 ± 5 78 ± 5 < 0.0001
BMI (kg/m2) 26 ± 5 27 ± 4 0.018
EF (%) 52 ± 13 55 ± 12 0.122
COPD 34 (35) 14 (20) 0.030
Cancer 20 (21) 15 (21) 0.480
Cerebrovascular disease 22 (22) 8 (11) 0.060
GFR pre (ml/min/1,73m2) 33 ± 12 38 ± 12 0.002
GFR post (ml/min/1,73m2) 35 ± 14 42 ± 17 0.001
PVD 32(33) 4 (6) 0.001
Hypertension 68 (70) 51 (72) 0.731
Diabetes 28 (29) 17 (24) 0.545
Smoking 13 (13) 8 (11) 0.698
Cholesterol (mmol/L) 4.7 ± 1.2 4.9 ± 1.1 0.322
PAP 40 ± 14 33 ± 10 0.001
CAD 69 (70) 42 (59) 0.323
Previous CABG 32 (33) 1 (1) < 0.0001
New CABG 0 (0) 31 (44) < 0.0001
Previous PCI 48 (49) 13 (18) 0.002
Pacemaker 13 (13) 5 (7) 0.252
LBBB 11 (11) 6 (9) 0.554
Heart failure < 2 weeks 80 (82) 43 (61) 0.002
CK MB post (U/L) 19 ± 58 28 ± 20 0.224
NT-proBNP (ng/L) 5416 ± 7920 1422 ± 2341 < 0.0001
NYHA III-IV pre 88 (89) 50 (70) 0.002
NYHA III-IV post 4 (6) 2 (3) 0.210
LogEuroScore 25 ± 13 10 ± 6 < 0.0001
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disease, and prevalence of LBBB and post-operative 
functional NYHA class III-IV between the two groups. 
Comparing diastolic echocardiographic parameters 
and NT-proBNP levels in patients who were 80 years 
or older to patients younger than 80 years, we found no 
differences regarding mitral-inflow and tissue-Doppler 
parameters. We observed a borderline significantly 
higher LAVI in the older patients, while only NT-proBNP 
and PAP values in the older patients were significantly 
higher compared to those younger than 80 years.
Figure 1 shows a typical example for changes of mitral 
and tissue Doppler flow before and after TAVR/SAVR 
and Table 2 displays the comparison of diastolic param-
eters. For this analysis we calculated the mean-value 
between both follow-up visits. Paired t-test for all param-
eters comparing the first and second follow-up visit did 
not show any significant difference. As expected, most 
of the diastolic functional parameters improved after the 
TAVR/SAVR. In particular, NT-proBNP, PAP and PV SFF 
values were significantly decreased, and IVRT, lateral e′ 
and average e′, E DT and MV E/A values were signifi-
cantly increased after the TAVR/SAVR procedure.
Using the 2016 ASE/EACVI recommended cut of val-
ues, we found 33 of 382 (8.6%) of measurements with 
PAP > 40 mmHg, 233 of 392 (59%) with E/e′ > 14 cm/s, 
336 of 393 (85%) with LAVI> 34 ml/m2 and 346 of 392 
(88%) with septal e′ < 7 cm/s. The NT-proBNP level was 
found to be ≥500 ng/L in 256 of 388 (66%) visits.
Figure  2 and Table  3 display the results of the ROC 
curve analysis of the ability of echocardiographic dias-
tolic parameters to predict high NT-proBNP levels (≥ 
500 ng/L). The same ROC curve analysis was also sepa-
rately performed for pre- and post AVR visits. These 
tables are added as supplementary material, showing no 
significant difference between AUCs or sensitivity/speci-
ficity at the same cut-off values. Even though NT-proBNP 
after AVR was significantly reduced, the diastolic proper-
ties after afterload-reduction indicate persistent diastolic 
dysfunction.
Table  4 shows the results of the univariable and mul-
tivariable regression analyses of the same echocar-
diographic diastolic parameters to determine high 
NT-proBNP levels. Septal and average e′, septal, lateral 
and average E/e′, PV SFF, LA volume, MV peak E, MV 
DT and PAP showed significant correlation with high 
NT-proBNP levels, whereas lateral e′, MV peak A, MV 
E/A and IVRT showed no significant correlation in uni-
variable regression analysis. Multivariable regression 
analysis revealed septal e′ and E/e′, MV DT and PAP as 
independent significant markers of high NT-proBNP 
levels.
Table 5 displays cut-off values based on high sensitivity 
(left row), intermediate sensitivity and specificity (middle 
row) and high enough specificity to reliably indicate the 
presence of elevated filling pressure (right row). For the 
scoring the value − 1 was applied for negative scoring 
using cut-off A, 0 (indeterminate) for results between 
cut-off A and C and + 1 for positive scoring using cut-
off C. For each of the four scoring-parameters, a value 
was applied and the sum of ≥1.0 indicated increased 
NT-proBNP, while a score of ≤ − 1 indicate normal NT-
proBNP. The scoring-algorithm is displayed in Fig.  3. 
Specificity for the ASE/EACVI recommended algorithm 
was 23% in the AS population, while our suggested scor-
ings with adjusted cut-off values displayed acceptable 
specificities (> 80%).
Discussion
This study demonstrates range and distribution of echo-
cardiographic parameters in the elderly population with 
high grade aortic stenosis. Independent predictors of ele-
vated NT-proBNP levels (> 500 ng/L) are PAP, mitral peak 
E, DT and septal E/e′ or septal e′ which can be used inter-
changeably. Parameters which are recommended for the 
assessment of diastolic dysfunction according to the 2016 
ASE and EACVI guidelines (i.e. high average E/e′, low 
septal e velocity, high TR velocity and high LAVI) result 
in comparable AUC in ROC curve analyses as reported in 
the guidelines. However, specificities at sensitivity > 60%; 
> 45% could be increased from 23 to > 75%; 85%, respec-
tively, by appropriate change of threshold-values.
Diastolic dysfunction in aortic stenosis, hemodynamic 
considerations
Aortic stenosis modifies ventricular diastolic properties 
with three different mechanisms:
1. Delayed relaxation and relaxation velocity of the 
mitral ring might be associated with increased after-
load and left ventricular hypertrophy [18]. Filling 
pressures can be normal in delayed relaxation [18]. 
Delayed relaxation velocity is expressed by reduced 
e′ in the septal or lateral ventricular wall. Low pres-
sure gradient due to low ventricular pressure fall and 
prolonged early filling period are reflected by low E 
velocity, prolonged IVRT and prolonged DT [19].
2. Increased filling pressures can be determined by 
invasive measurement of ventricular pre-A pressure, 
which is a condition often followed by increased end-
diastolic pressure and pulmonary capillary wedge 
pressure (PCWP). Increased filling pressures in AS 
are often reversible and can occur at superimposed 
afterload in a ventricle with reduced relaxation prop-
erties and initially normal filling pressures [18]. Fill-
ing pressures can typically occur at decreased stroke 
volume, shortened diastole during tachycardia or at 
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missing compensatory atrial filling in atrial fibril-
lation. Increased diastolic pressure gradients are 
associated with higher E velocities, shortened DT 
and IVRT, reduced PV SFF and higher PAP [4, 19]. 
Additionally, LA size and E/é are associated with 
increased PCWP at rest and during exercise [20].
Fig. 1 Example for mitral valve and tissue-Doppler parameters before and after aortic valve replacement (AVR); Upper panel: TI: tricuspid 
insufficiency; Vmax: maximal velocity; Mid panel: Mitral flow: E vel: E-wave velocity; E/A: ratio og E-wave and A-wave velocity; DT: deceleration time; 
Lower panel: Tissue Doppler: s’: peak systolic velocity; e’: peak e-velocity
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Table 2 Distribution of diastolic measurements in patients with severe aortic stenosis
2009 Criteria for Grade I, II or III diastolic dysfunction were septal e′ < 8, lateral e′ < 10, LA ≥34 ml/m2, displayed is the number of criteria met
A Late (atrial) diastolic transmitral flow velocity, E Early diastolic transmitral flow velocity, e′ Early diastolic mitral annuler velocity, IVRT Isovolumic relaxation time, LA 
Left atrium, MV dec time Mirtal valve deceleration time, MV peak E Mitral valve early diastolic filling velocity, MV peak A Mitral valve late diastolic atrial filling velocity, 
NT-proBNP N-terminal prohormone of brain natriuretic peptide, PAP Pulmonary artery pressure, PV SFF Pulmonary veins systolic filling fraction, SAVR Surgical aortic 
valve replacement, TAVR Transcatheter aortic valve replacement
n Range; percent within range (%) Mean ± SD P (Chi Square)
Range (cm/s) < 5 5–7 7–10 ≥10
e’septal (cm/s) Before SAVR/TAVR 128 65% 24% 9% 2% 5.1 ± 3.9 0.166
After SAVR/TAVR 132 53% 36% 10% 1% 5.2 ± 1.6
e’lateral (cm/s) Before SAVR/TAVR 128 31% 35% 29% 5% 6.3 ± 2.1 < 0.0001
After SAVR/TAVR 132 12% 34% 38% 16% 7.7 ± 2.7
e’avrg (cm/s) Before SAVR/TAVR 128 44% 36% 18% 2% 5.7 ± 2.4 < 0.0001
After SAVR/TAVR 132 21% 45% 33% 2% 6.5 ± 1.8
Range (cm/s) < 8 8–12 12–16 16–20 ≥20
E/e’sept () Before SAVR/TAVR 125 3% 7% 18% 22% 50% 22 ± 11 0.222
After SAVR/TAVR 130 3% 14% 24% 20% 39% 20 ± 10
E/e’lat () Before SAVR/TAVR 128 7% 26% 25% 17% 25% 16 ± 8 0.051
After SAVR/TAVR 132 13% 36% 24% 12% 14% 14 ± 7
E/e’avrg () Before SAVR/TAVR 127 5% 12% 28% 26% 30% 19 ± 8 0.014
After SAVR/TAVR 132 5% 28% 27% 23% 18% 16 ± 7
Range (ms) < 60 60–80 80–100 100–120 > 120
IVRT Before SAVR/TAVR 128 40% 26% 17% 9% 7% 70 ± 44 0.007
After SAVR/TAVR 123 24% 22% 21% 20% 13% 90 ± 54
Range (mmHg) < 30 30–40 40–50 ≥50
PAP Before SAVR/TAVR 122 17% 47% 22% 14% 39 ± 8 0.046
After SAVR/TAVR 130 22% 55% 19% 5% 36 ± 8
Range (%) < 25 25–40 50–60 50–80
PV SFF Before SAVR/TAVR 133 5% 17% 40% 38% 51 ± 17 0.048
After SAVR/TAVR 133 9% 17% 50% 23% 49 ± 14
Range (ml/m2) < 34 34–50 50–75 > 75
LA volume Index Before SAVR/TAVR 123 16% 33% 45% 7% 52 ± 20 0.093
After SAVR/TAVR 129 16% 46% 33% 7% 50 ± 23
Range (cm/s) < 50 50–80 80–110 > 110
MV peak E Before SAVR/TAVR 130 4% 28% 27% 42% 96 ± 32 0.415
After SAVR/TAVR 132 3% 36% 21% 40% 95 ± 32
MV peak A Before SAVR/TAVR 102 10% 13% 26% 52% 102 ± 32 0.299
After SAVR/TAVR 102 2% 22% 21% 56% 105 ± 28
Range () < 0.5 0.5–0.8 0.8–1.1 ≥1.1
MV E/A () Before SAVR/TAVR 101 13% 43% 27% 18% 1.0 ± 0.6 0.009
After SAVR/TAVR 101 10% 41% 40% 11% 1.0 ± 0.4
Range (ms) < 150 150–220 220–280 > 280
E decel time Before SAVR/TAVR 130 13% 30% 19% 39% 251 ± 95 0.050
After SAVR/TAVR 132 5% 28% 30% 37% 260 ± 76
Range (ng/L) < 500 500–850 850–1700 1700–5000 > 5000
NT-proBNP Before SAVR/TAVR 119 23% 16% 19% 30% 13% 3168 ± 6270 < 0.0001
After SAVR/TAVR 120 43% 19% 21% 13% 4% 1274 ± 2238
Range () 0 (Normal) 1 (Normal) 2 (inde-terminate) 3 (positive) 4 (positive)
Score 2016 Before SAVR/TAVR 117 3% 9% 22% 40% 26% 2.7 ± 1.0 0.071
After SAVR/TAVR 128 2% 13% 35% 36% 15% 2.5 ± 1.0
Range () 0 (Normal) 1 2 3
2009 Criteria for 
Grade I, II or III
Before SAVR/TAVR 127 1% 8% 20% 72% 2.6 ± 1 < 0.0001
After SAVR/TAVR 130 2% 20% 28% 51% 2.3 ± 1
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3. Ventricular hypertrophy, fibrosis and molecular 
mechanisms of diastolic dysfunction [21] might affect 
ventricular relaxation, and might also increase ven-
tricular stiffness. These conditions, in turn, increase 
LV filling pressures with a non-reversible component 
after afterload reduction, and might contribute to 
persistently elevated NT-proBNP levels after TAVR/
SAVR.
Impaired relaxation in elderly AS patients
Most echocardiographic parameters of diastolic dys-
function have a U-shaped function with normal values 
between two extremes of either impaired relaxation or 
increased filling pressures [19]. For correct interpreta-
tion of indicators on increased filling pressures, diastolic 
properties of the LV at normal filling pressures in AS 
need to be considered. Results of our study and previous 
Fig. 2 ROC curve analyses of echocardiographic diastolic parameters for NT-proBNP ≥500 ng/L. DT;deceleration time, E; early diastolic transmitral 
flow velocity, e′; early diastolic mitral annuler velocity, LA; left atrium, PAP; pulmonary artery pressure,, PV SFF; pulmonary veins systolic filling 
fraction, ROC; receiver operating characteristic
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investigations [5, 20, 22] on diastolic parameters in AS, 
indicate that most AS LVs predominantly display signs 
of impaired relaxation. This is reflected by low e′, which 
increases after TAVR/SAVR, though without complete 
normalization [10, 23].
Table 3 ROC curve analysis of echocardiographic parameters to predict NT-proBNP ≥500 ng/L in patients with severe aortic stenosis
A Late (atrial) diastolic transmitral flow velocity, AUC Area Under the Curve, CI Confidence interval, E Early diastolic transmitral flow velocity, e′ Early diastolic mitral 
annuler velocity, IVRT Isovolumic relaxation time, LA Left atrium, MV dec time Mirtal valve deceleration time, MV peak E Mitral valve early diastolic filling velocity, MV 
peak A Mitral valve late diastolic atrial filling velocity, NT-proBNP N-terminal prohormone of brain natriuretic peptide, PAP Pulmonary artery pressure, ROC Receiver 
operating characteristic
N = 210 NT-proBNP ≥500
N = 123 NT-proBNP < 500
AUC CI Lower bound CI Upper bound P-value
e’septal (cm/s) 0.68 0.62 0.73 < 0.0001
e’lateral (cm/s) 0.62 0.55 0.68 0.001
e’avrg (cm/s) 0.62 0.56 0.68 0.002
E/e’sept () 0.70 0.65 0.76 < 0.0001
E/e’lat () 0.63 0.56 0.69 < 0.0001
E/e’avrg () 0.67 0.61 0.73 < 0.0001
PV SFF 0.68 0.63 0.74 < 0.0001
LA volume (ml) 0.73 0.67 0.79 < 0.0001
MV peak E (cm/s) 0.64 0.58 0.70 0.050
MV peak A (cm/s) 0.50 0.44 0.57 0.939
MV E/A () 0.57 0.51 0.64 0.037
MV dec time (ms) 0.66 0.61 0.72 < 0.0001
IVRT (ms) 0.56 0.50 0.62 0.057
PAP (mmHg) 0.68 0.63 0.74 < 0.0001
Score 2016 0.72 0.67 0.78 < 0.0001
Score 1 e’sept 0.76 0.71 0.82 < 0.0001
Score 2 E/é avrg 0.70 0.65 0.77 < 0.0001
Table 4 Univariate and multivariate regression analysis for indicators of elevated NT-proBNP (≥500 ng/L)
*E’sept or E/é avrg exclude each other in the equation and can be used interchangeably
A Late (atrial) diastolic transmitral flow velocity, E Early diastolic transmitral flow velocity, e′ Early diastolic mitral annuler velocity, IVRT Isovolumic relaxation time, LA 
Left atrium, MV dec time Mirtal valve deceleration time, MV peak E Mitral valve early diastolic filling velocity, MV peak A Mitral valve late diastolic atrial filling velocity, 
NT-proBNP N-terminal prohormone of brain natriuretic peptide, PAP Pulmonary artery pressure, PV SFF Pulmonary veins systolic filling fraction
Univariate regression (Unadjusted model) Multivariate regression (Adjusted model)
OR 95% CI 95%C I p-value OR 95% CI 95% CI p-value
e’septal (cm/s) 0.731 0.632 0.845 < 0.0001 1.196 1.118 1.279 < 0.0001*
e’lateral (cm/s) 0.921 0.847 1.002 0.056
e’avrg (cm/s) 0.807 0.713 0.913 0.001
E/e’sept () 1.108 1.071 1.147 < 0.0001 1.196 1.118 1.1279 < 0.0001*
E/e’lat () 1.079 1.039 1.127 < 0.0001
E/e’avrg () 1.090 1.040 1.142 < 0.0001
PV SFF 0.947 0.929 0.965 < 0.0001
LA volume (ml) 1.022 1.013 1.030 < 0.0001
MV peak E (cm/s) 1.019 1.010 1.027 < 0.0001 0.965 0.949 0.982 0.001
MV peak A (cm/s) 0.999 0.991 1.007 0.782
MV E/A () 2.278 1.210 4.289 0.011
MV dec time (ms) 0.994 0.991 0.997 < 0.0001 0.994 0.991 0.998 0.001
IVRT (ms) 0.997 0.993 1.001 0.192
PAP (mmHg) 1.114 1.097 1.192 < 0.0001 1.095 1.039 1.154 0.001
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Age alone is one important factor for reduced relaxa-
tion properties. However, the patient population with 
TAVR, typically ages > 75 years, is scarcely represented 
in epidemiological studies [24] or in control groups of 
clinical studies. Probably due to the low number of study 
subjects, the 2016 ASE and EACVI guidelines refer to the 
high age group as > 60 years [4].
Compared to the high age group of the guidelines, the 
septal and lateral e′ are significantly lower, and LAVI and 
DT are significantly higher in the present study. To a 
smaller extent, age might reduce relaxation properties in 
higher age groups, however, most of the diastolic param-
eters were not different between the two age groups ≥80 
and < 80 years in the present study.
Steine et  al. [5] investigated patients (65 ± 12 years) 
with moderate AS, showing decreased septal e′ and 
increased atrial velocity compared to age-matched con-
trols. Furthermore, E velocity, DT and E/e′ ratio were 
highly elevated compared to age-matched controls 
(17,4 ± 10 vs 11 ± 4) [5]. These results demonstrate that 
AS has age independent effects on ventricular diastolic 
properties.
Even though the present study represents an older 
patient population with higher degree of AS compared 
to Steines and other younger study populations [5, 10, 
23, 25], we found a similar reduction of e′. Our results 
stress the predominance of factors other than age like 
LV hypertrophy, changed LV stiffness and increased 
afterload as the main reasons for decreased relaxation 
properties in AS patients. PAP was the only diastolic 
echocardiographic parameter which was significantly 
different between age-groups. One explanation of this 
could be low LV compliance with elevated filling pres-
sures due to diffuse myocardial fibrosis in the elderly 
patients. Another explanation might be the high number 
of COPD patients in the elderly TAVR group.
Changes of diastolic properties after TAVR/SAVR
Even though e′ increases after TAVR/SAVR [10, 23, 
25–27], average e′ stayed lower than 10 cm/s in 90% of 
postoperative AS patients, indicating persistent impaired 
relaxation also after afterload reduction with AVR. Post-
operatively, relaxation velocities in the lateral but not 
septal wall were significantly higher than pre-operative 
values, suggesting regionally inhomogeneous response to 
reduced afterload.
The correlation of e′ and improvement of s′ and their 
increase after AVR, indicate an association between ven-
tricular contraction and relaxation velocities, which are 
both influenced by afterload changes [18, 28]. These find-
ings point to afterload dependent, reversible reduction of 
contraction and relaxation velocities of the lateral wall, 
whereas the bulky, structurally changed septum of hyper-
tensive ventricles [29] have less ability to recover. The 
majority of previous studies report a similar degree of 
diastolic dysfunction in AS patients with reduced recov-
ery of relaxation properties [10, 23, 25–27], while only 
one study could be identified describing normalized E/e′, 
e′ and LA volume post TAVR [2]. It can be assumed that 
1 year follow up might mainly reflect reduction of filling-
pressures as shown by substantially lowered NT-pro BNP, 
while relaxation properties might be more dependent on 
Fig. 3 Scoring for elevated filling pressures based on the results of the present study
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a slower process of re-remodeling. If impaired relaxation 
is fully reversible, has to be shown in future long-term 
follow-up studies.
Kjønås et  al. investigated echocardiographic systolic 
and diastolic parameters as predictors of mortality in the 
TAVR population of this study. These data showed that 
only increased pulmonary artery pressure was a predic-
tor for early death, while other echocardiographic param-
eters of systolic or diastolic function did not indicate the 
outcome during the first 2 years.
Indicators for increased filling pressures
The present study refers to the 2016 ASE/EACVI recom-
mendations for the evaluation of LV diastolic dysfunction 
[4], which propose a simplified approach of estimating 
increased filling pressures (i.e. grade II and grade III of 
diastolic dysfunction). For assessment of impaired relaxa-
tion (i.e. Grade I diastolic dysfunction) we refer to the 
better definition of this state in the recommendations of 
2009 [19].
The current results reflect the difficulties of estimating 
filling pressures in ventricles with highly impaired relaxa-
tion. Impaired relaxation will naturally change thresh-
olds for increased filling pressures due to the U-shaped 
function of many Doppler-based parameters. This applies 
for mitral peak E velocity, DT, IVRT and PV SFF [12]. In 
opposite, the parameters e′ increases and E/e′ decreases 
with an additive effect of both, impaired relaxation and 
increased filling pressures. In AS patients, E/e′ seem to 
be predominantly influenced by ventricular relaxation 
properties (i.e. e′) rather than mitral pressure gradients 
(i.e. E velocity). Thus, e′ is lower in AS patients, while 
E-wave velocities are not elevated compared to age-
matched controls [4, 5]. Similarly, comparing pre- and 
post AVR parameters shows that reduction of E/e′ was 
mainly related to postoperatively increasing e′, while E 
velocity was unchanged.
NT-proBNP
Plasma NT-proBNP levels correlate well with elevated 
filling pressures in many different settings [1, 11, 13]. For 
this reason, in the present study, NT-proBNP was cho-
sen as a marker for increased end-diastolic pressures. The 
cut-off NT-proBNP value of 500 ng/L was derived from 
the clinical normalcy range for females between 70 and 
80 years and males ≥70 years, appropriate for the major-
ity of our patients.
Significantly reduced NT-proBNP levels after AVR 
indicate moderately improved but not normalized fill-
ing pressures following afterload reduction. ROC curve 
analyses for several diastolic parameters distinguish high 
and low NT-proBNP values with AUC values between 
65 and 76%, which indicates moderate diagnostic value 
when values are measured in the intermediate range. In 
line with our findings, Sasaki et al. showed that E/e′ was a 
highly sensitive and specific predictor of NT-proBNP lev-
els, even after adjustment for clinical and systolic param-
eters [14]. Notably, in the present study, E/e′ was not 
superior to low septal e′ as a marker for high NT-proBNP 
levels. Even though high E/é is a widely used marker for 
elevated filling pressures [1, 11, 14], changes in filling are 
thought to be driven by changing peak E velocity, while 
low e′ is thought to be closer related to impaired relaxa-
tion [19]. However, the close correlation of e′ to NT-
proBNP indicate that afterload and filling pressures have 
a direct influence on e′. A previous experimental study 
[18], tried to explain this inverse correlation by showing 
partially irreversible relation of impaired relaxation to 
increased filling pressures. Interestingly, peak E velocity 
showed low correlation with E/e′ or e′, and appeared to 
be an independent predictor of high NT-proBNP.
High PAP is a consistent and independent marker of 
elevated filling pressures [1, 4, 14] and a predictor for 
outcomes after TAVR and SAVR [25, 30]. In accordance 
with previous findings, high PAP values showed inde-
pendent correlation with elevated NT-proBNP levels [1]. 
In consistency with the 2016 guidelines, this study shows 
that PAP is the most specific prognosticator with incre-
mental effect to other parameters for detection of high 
filling pressures.
Clinical implication
Preoperatively and postoperatively, 91 and 78% of 
patients with AS, respectively, displayed at least 2–3 of 3 
criteria of grade I-III diastolic dysfunction, which include 
septal e′, lateral e′, LAVI, according to the 2009 ASE/
EACVI guidelines.
Following the 2016 guidelines, all mitral flow and tis-
sue-Doppler based parameters indicated elevated filling 
pressures in the majority of AS patients with unaccept-
ably low specificity (25%). Only TR velocity > 2.8 m/s 
indicated high NT-proBNP levels with high specificity at 
acceptable sensitivity.
According to the results of the present study, we sug-
gest the use of an adjusted model for elderly patients with 
AS by taking the following considerations into account:
First, E/e′ and e’are good indicators of elevated filling 
pressures. Because of high correlation with each other, 
they have no significant additive value and can be used 
interchangeably. Septal or average E/e′ and e′ seemed to 
be more accurate than lateral e′ measurements in assess-
ment of increased filling pressure.
Second, LA volume was not a significant indicator 
of increased NT-proBNP levels and thus of lesser value 
in the assessment of increased filling pressures in AS 
patients. LA size changes with atrial fibrillation, which 
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was present in 25% of the AS patients, and it increased 
due to impaired relaxation which is present in the major-
ity of AS patients. LA size might be a better indicator 
for long-term increased filling pressures when seperat-
edly assessed for patients with sinus-rhythm or atrial 
fibrillation.
Third, our study confirms a highly specific PAP cut-
off level of 40 mmHg which is the equivalent of TR peak 
velocity of 2.8 m/s suggested in the 2016 guidelines.
Fourth, E wave velocity and E DT, are independent 
indicators of elevated NT-proBNP levels in the multiple 
logistic regression analysis. E wave velocity decreases 
and DT is prolonged after AVR, indicating a closer rela-
tionship with reversible pressures. However, E veloc-
ity, DT, E/e′ and e′ cut-off values have to be adjusted 
towards cut-off values with higher specificities to be 
relevant for clinical use. According to our results, at 
least one of the following parameters need to cross their 
thresholds to indicate high filling pressures in patients 
with pre- or postoperative aortic stenosis: E/e’sept > 20; 
E velocity > 100 cm/s; DT < 220 ms; PAP > 40 mmHg or 
e’sept < 5.0 cm/s.
Limitation of the study
The gold standard for diastolic filling pressures is inva-
sive pressure measurements by right or left-heart cath-
eter, which were not available in the present study. We 
used NT-proBNP as a surrogate marker of increased 
filling pressure, as previously practiced in other stud-
ies [17, 19]. Even though NT-proBNP correlates well 
with diastolic pressures, it is not known whether age 
alone increases proBNP. Setting the cut-off value of NT-
proBNP at 500 ng/L did not take age-adjusted normalcy 
into account. However, a model with age-adjusted cut-off 
values for NT-proBNP was tested and rendered similar 
results.
The present study was performed on one ultrasound-
system and the same reader, resulting in highly robust 
tissue velocity measurements. However, tissue Doppler 
indices are known to differ between ultrasound-systems 
with vendor specific machine-settings [31]. Comparison 
of E/e′ and e′ and cut-off values with guidelines or other 
studies are therefore challenging as varying results might 
be due to systematic errors.
In the TAVR population of this study, we could show 
that pulmonary hypertension is a strong predictor for 
early death [30]. Early drop-out of the patients with pul-
monary hypertension might have influenced the postop-
erative echocardiographic measurements. However, the 
supplementary tables S1 and S2 indicate that sensitivity 
and specificity for elevated NT-proBNP pre- and post 
AVR is similar during the first year.
Many factors like valvular heart disease, atrial fibril-
lation, ejection fraction, age, gender, ischemic heart 
disease, hypertension, amyloidosis, mitral ring calcifi-
cation [32] and others are known to influence diastolic 
properties of the heart. Unfortunately, the study popu-
lation was too small to correct our results for all these 
factors. Larger studies based on echocardiography need 
to be conducted in order to take all these factors into 
account.
Conclusion
Diastolic echocardiographic parameters in AS indicate 
persistent impaired relaxation and NT-proBNP indicate 
higher filling pressures in most of the patients, improv-
ing only modestly 6–12 months after TAVR and SAVR. 
Applying the 2016 ASE/EACVI recommendations for 
detection of elevated filling pressures to patients with 
AS, elevated NT pro-BNP levels could not be reliably 
detected. However, adjusting thresholds of the echocar-
diographic parameters increased specificities to useful 
diagnostic levels.
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